Clinical features and prognostic factors in adults with brain abscess.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
19 04 2023
Historique:
received: 10 05 2022
revised: 23 07 2022
accepted: 15 08 2022
medline: 21 4 2023
pubmed: 30 8 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

Studies on brain abscess are hampered by single-centre design with limited sample size and incomplete follow-up. Thus, robust analyses on clinical prognostic factors remain scarce. This Danish nationwide, population-based cohort study included clinical details of all adults (≥18 years) diagnosed with brain abscess in the Danish National Patient Registry from 2007 through 2014 and the prospective clinical database of the Danish Study Group of Infections of the Brain covering all Danish departments of infectious diseases from 2015 through 2020. All patients were followed for 6 months after discharge. Prognostic factors for mortality at 6 months after discharge were examined by adjusted modified Poisson regression to compute relative risks with 95% confidence intervals (CI). Among 485 identified cases, the median age was 59 years [interquartile range (IQR 48-67)] and 167 (34%) were female. The incidence of brain abscess increased from 0.4 in 2007 to 0.8 per 100 000 adults in 2020. Immuno-compromise was prevalent in 192/485 (40%) and the clinical presentation was predominated by neurological deficits 396/485 (82%), headache 270/411 (66%), and fever 208/382 (54%). The median time from admission until first brain imaging was 4.8 h (IQR 1.4-27). Underlying conditions included dental infections 91/485 (19%) and ear, nose and throat infections 67/485 (14%), and the most frequent pathogens were oral cavity bacteria (59%), Staphylococcus aureus (6%), and Enterobacteriaceae (3%). Neurosurgical interventions comprised aspiration 356/485 (73%) or excision 7/485 (1%) and was preceded by antibiotics in 377/459 (82%). Fatal outcome increased from 29/485 (6%) at discharge to 56/485 (12%) 6 months thereafter. Adjusted relative risks for mortality at 6 months after discharge was 3.48 (95% CI 1.92-6.34) for intraventricular rupture, 2.84 (95% CI 1.45-5.56) for immunocompromise, 2.18 (95% CI 1.21-3.91) for age >65 years, 1.81 (95% CI 1.00-3.28) for abscess diameter >3 cm, and 0.31 (95% CI 0.16-0.61) for oral cavity bacteria as causative pathogen. Sex, neurosurgical treatment, antibiotics before neurosurgery, and corticosteroids were not associated with mortality. This study suggests that prevention of rupture of brain abscess is crucial. Yet, antibiotics may be withheld until neurosurgery, if planned within a reasonable time period (e.g. 24 h), in some clinically stable patients. Adjunctive corticosteroids for symptomatic perifocal brain oedema was not associated with increased mortality.

Identifiants

pubmed: 36037264
pii: 6678645
doi: 10.1093/brain/awac312
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1637-1647

Investigateurs

Merete Storgaard (M)
Lykke Larsen (L)
Birgitte Rønde Hansen (BR)
Christian Østergaard Andersen (CØ)
Lothar Wiese (L)
Christian Thomas Brandt (CT)
Jannik Helweg-Larsen (J)
Hans Rudolf von Lüttichau (HR)
Henrik Nielsen (H)
Jacob Bodilsen (J)

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jacob Bodilsen (J)

Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark.

Lærke Storgaard Duerlund (LS)

Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark.

Theis Mariager (T)

Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark.

Christian Thomas Brandt (CT)

Department of Pulmonary- and Infectious Diseases, Nordsjællands Hospital, 3400 Hillerød, Denmark.

Pelle Trier Petersen (PT)

Department of Pulmonary- and Infectious Diseases, Nordsjællands Hospital, 3400 Hillerød, Denmark.

Lykke Larsen (L)

Department of Infectious Diseases, Odense University Hospital, 5000 Odense, Denmark.

Birgitte Rønde Hansen (BR)

Department of Infectious Diseases, Hvidovre University Hospital, 2650 Hvidovre, Denmark.

Lars Haukali Omland (LH)

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.

Malte Mose Tetens (MM)

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.

Lothar Wiese (L)

Department of Infectious Diseases, Sjælland University Hospital, 4000 Roskilde, Denmark.

Rasmus Langelund Jørgensen (RL)

Department of Neurosurgery, Aarhus University Hospital, Skejby, 8200 Aarhus N, Denmark.

Steffen Leth (S)

Department of Infectious Diseases, Aarhus University Hospital, 8200 Aarhus N, Denmark.
Department of Infectious Diseases, Internal Medicine, Gødstrup Hospital, 7400 Gødstrup, Denmark.

Henrik Nielsen (H)

Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark.
Institute for Clinical Medicine, Aalborg University Hospital, 9000 Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH